{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T09:04:14Z","timestamp":1774343054129,"version":"3.50.1"},"reference-count":10,"publisher":"Informa UK Limited","issue":"11","funder":[{"name":"funding agencies in the public, commercial, or not-for-profit sectors"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2021,11,2]]},"DOI":"10.1080\/21645515.2021.1954826","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T20:37:56Z","timestamp":1628109476000},"page":"4093-4096","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":37,"title":["Electromyoneurography and laboratory findings in a case of Guillain-Barr\u00e9 syndrome after second dose of Pfizer COVID-19 vaccine"],"prefix":"10.1080","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1910-2405","authenticated-orcid":false,"given":"Roberto","family":"Scendoni","sequence":"first","affiliation":[{"name":"Macerata Territorial Health Department, Legal Medicine Unit ASUR Marche AV3, Macerata, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Petrelli","sequence":"additional","affiliation":[{"name":"Neurological Unit ASUR Marche AV3, Macerata Hospital, Macerata, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Scaloni","sequence":"additional","affiliation":[{"name":"Hospital Medical Direction, ASUR Marche AV3, Macerata Hospital, Macerata, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco Ottavio","family":"Logullo","sequence":"additional","affiliation":[{"name":"Neurological Unit ASUR Marche AV3, Macerata Hospital, Macerata, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,8,4]]},"reference":[{"key":"e_1_3_2_2_1","unstructured":"Cascella M Rajnik M Cuomo A Dulebohn SC Di Napoli R. Features evaluation and treatment coronavirus (COVID-19). In StatPearls. Treasure Island FL: StatPearls Publishing; 2020 [accessed 2021 May 25]. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554776\/"},{"key":"e_1_3_2_3_1","first-page":"e7930","article-title":"Neurological complications of coronavirus disease (COVID- 19): encephalopathy, MRI brain and cerebrospinal fluid findings: case 2","volume":"12","author":"Espinosa PS","year":"2020","unstructured":"Espinosa PS, Rizvi Z, Sharma P, Hindi F, Filatov A. Neurological complications of coronavirus disease (COVID- 19): encephalopathy, MRI brain and cerebrospinal fluid findings: case 2. Cureus. 2020;12:e7930.","journal-title":"Cureus"},{"key":"e_1_3_2_4_1","first-page":"e7352","article-title":"Neurological complications of coronavirus disease (COVID- 19): encephalopathy","volume":"12","author":"Filatov A","year":"2020","unstructured":"Filatov A, Sharma P, Hindi F, Espinosa PS. Neurological complications of coronavirus disease (COVID- 19): encephalopathy. Cureus. 2020;12:e7352.","journal-title":"Cureus"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01230-y"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577"},{"key":"e_1_3_2_7_1","first-page":"e13426","article-title":"Neurological Complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine","volume":"13","author":"Waheed S","year":"2021","unstructured":"Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS. Neurological Complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine. Cureu.s. 2021;13:e13426.","journal-title":"Cureu.s"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26868"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awf272"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.42.457"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.3.717"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2021.1954826","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T15:02:32Z","timestamp":1709305352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2021.1954826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,4]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11,2]]}},"alternative-id":["10.1080\/21645515.2021.1954826"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2021.1954826","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-06-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}